New Drug Could Be Advance Against Glioma Brain Tumors
MONDAY, June 5, 2023 (HealthDay News) — An experimental targeted therapy can dramatically slow the progress of common slow-growing brain cancers, a new clinical trial finds. The oral drug vorasidenib nearly tripled progression-free survival in patients with grade 2 gliomas compared to placebo, nearly 28 months versus 11 months, accordingContinue Reading










